Franklin Street Advisors Inc Sangamo Therapeutics, Inc Transaction History

Franklin Street Advisors Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 18, 2022	SELL	$5.23 - $7.82 $294,605 - $440,500	-56,330 Closed	0 $0
Q4 2021 Jan 26, 2022	BUY	$7.29 - $10.97 $18,225 - $27,425	2,500 Added 4.64%	56,330 $422,000
Q3 2021 Oct 22, 2021	SELL	$9.01 - $12.01 $7,928 - $10,568	-880 Reduced 1.61%	53,830 $485,000
Q2 2021 Aug 05, 2021	BUY	$10.17 - $12.64 $447,480 - $556,160	44,000 Added 410.83%	54,710 $655,000
Q1 2021 May 04, 2021	SELL	$10.88 - $17.05 $22,521 - $35,293	-2,070 Reduced 16.2%	10,710 $134,000
Q3 2020 Oct 21, 2020	SELL	$9.38 - $12.48 $234,500 - $312,000	-25,000 Reduced 66.17%	12,780 $121,000
Q1 2020 Apr 16, 2020	BUY	$5.05 - $8.85 $126,250 - $221,250	25,000 Added 195.62%	37,780 $241,000
Q2 2019 Aug 07, 2019	BUY	$8.75 - $13.03 $7,700 - $11,466	880 Added 7.39%	12,780 $138,000
Q4 2018 Feb 14, 2019	SELL	$9.51 - $16.6 $275,790 - $481,400	-29,000 Reduced 70.9%	11,900 $137,000
Q3 2018 Oct 05, 2018	SELL	$13.05 - $19.05 $6,525 - $9,525	-500 Reduced 1.21%	40,900 $693,000
Q2 2018 Jul 16, 2018	BUY	$13.9 - $19.8 $13,900 - $19,800	1,000 Added 2.48%	41,400 $588,000
Q1 2018 Apr 11, 2018	SELL	$16.7 - $26.35 $96,860 - $152,830	-5,800 Reduced 12.55%	40,400 $768,000
Q4 2017 Jan 10, 2018	SELL	$11.6 - $17.35 $119,480 - $178,705	-10,300 Reduced 18.23%	46,200 $758,000
Q3 2017 Oct 11, 2017	BUY	$8.4 - $15.0 $474,600 - $847,500	56,500	56,500 $848,000

134

86.5M

35.9K

156K

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $266M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Franklin Street Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Franklin Street Advisors Inc with notifications on news.